Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Concepts and tools for mechanism and selectivity analysis in synthetic organic electrochemistry.

Costentin C, Savéant JM.

Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11147-11152. doi: 10.1073/pnas.1904439116. Epub 2019 May 17.

PMID:
31101717
2.

Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.

Faivre S, Santoro A, Kelley RK, Gane E, Costentin CE, Gueorguieva I, Smith C, Cleverly A, Lahn MM, Raymond E, Benhadji KA, Giannelli G.

Liver Int. 2019 Apr 8. doi: 10.1111/liv.14113. [Epub ahead of print]

PMID:
30963691
3.

Elucidation of a Redox-Mediated Reaction Cycle for Nickel-Catalyzed Cross Coupling.

Sun R, Qin Y, Ruccolo S, Schnedermann C, Costentin C, Daniel G Nocera.

J Am Chem Soc. 2019 Jan 9;141(1):89-93. doi: 10.1021/jacs.8b11262. Epub 2018 Dec 27.

PMID:
30563318
4.

Reply.

Costentin CE, Layese R, Roudot-Thoraval F, Audureau E, Nahon P; ANRS C012 CirVir group.

Gastroenterology. 2019 Jan;156(1):289-290. doi: 10.1053/j.gastro.2018.11.046. Epub 2018 Nov 23. No abstract available.

PMID:
30472229
5.

Effect of long term aspirin use on the incidence of prostate cancer: A systematic review and meta-analysis.

Sauer CM, Myran DT, Costentin CE, Zwisler G, Safder T, Papatheodorou S, Mucci LA.

Crit Rev Oncol Hematol. 2018 Dec;132:66-75. doi: 10.1016/j.critrevonc.2018.09.013. Epub 2018 Sep 29.

PMID:
30447928
6.

18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: A prospective observational study.

Lim C, Salloum C, Chalaye J, Lahat E, Costentin CE, Osseis M, Itti E, Feray C, Azoulay D.

HPB (Oxford). 2019 Jun;21(6):739-747. doi: 10.1016/j.hpb.2018.10.007. Epub 2018 Nov 3.

PMID:
30401520
7.

Homogeneous Molecular Catalysis of Electrochemical Reactions: Manipulating Intrinsic and Operational Factors for Catalyst Improvement.

Costentin C, Savéant JM.

J Am Chem Soc. 2018 Dec 5;140(48):16669-16675. doi: 10.1021/jacs.8b09154. Epub 2018 Nov 16.

PMID:
30392356
8.

Direct Electrochemical P(V) to P(III) Reduction of Phosphine Oxide Facilitated by Triaryl Borates.

Elias JS, Costentin C, Nocera DG.

J Am Chem Soc. 2018 Oct 24;140(42):13711-13718. doi: 10.1021/jacs.8b07149. Epub 2018 Oct 16.

PMID:
30278122
9.

Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased-Donor Liver Transplantation?

Costentin CE, Bababekov YJ, Zhu AX, Yeh H.

Hepatology. 2019 Mar;69(3):1324-1336. doi: 10.1002/hep.30278. Review.

PMID:
30229978
10.

Ligand "noninnocence" in coordination complexes vs. kinetic, mechanistic, and selectivity issues in electrochemical catalysis.

Costentin C, Savéant JM, Tard C.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9104-9109. doi: 10.1073/pnas.1810255115. Epub 2018 Aug 24.

11.

Oxygen activation at a dicobalt centre of a dipyridylethane naphthyridine complex.

Brodsky CN, Passard G, Ullman AM, Jaramillo DE, Bloch ED, Huynh M, Gygi D, Costentin C, Nocera DG.

Dalton Trans. 2018 Aug 29;47(34):11903-11908. doi: 10.1039/c8dt01598h.

PMID:
29942938
12.

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.

Costentin CE, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouzé E, Imbeaud S, Zucman-Rossi J, Audureau E, Roudot-Thoraval F, Nahon P; ANRS CO12 CirVir Group.

Gastroenterology. 2018 Aug;155(2):431-442.e10. doi: 10.1053/j.gastro.2018.04.027. Epub 2018 May 3.

PMID:
29729258
13.

Reply to: "Response to: Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma".

Chalaye J, Costentin CE, Luciani A, Nault JC.

J Hepatol. 2018 Aug;69(2):555-556. doi: 10.1016/j.jhep.2018.04.020. Epub 2018 Apr 30. No abstract available.

PMID:
29719212
14.

Properties of Site-Specifically Incorporated 3-Aminotyrosine in Proteins To Study Redox-Active Tyrosines: Escherichia coli Ribonucleotide Reductase as a Paradigm.

Lee W, Kasanmascheff M, Huynh M, Quartararo A, Costentin C, Bejenke I, Nocera DG, Bennati M, Tommos C, Stubbe J.

Biochemistry. 2018 Jun 19;57(24):3402-3415. doi: 10.1021/acs.biochem.8b00160. Epub 2018 Apr 17.

15.

Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.

Costentin CE, Mourad A, Lahmek P, Causse X, Pariente A, Hagège H, Dobrin AS, Becker C, Marks B, Bader R, Condat B, Héluwaert F, Seitz JF, Lesgourgues B, Denis J, Deuffic-Burban S, Rosa I, Decaens T; CHANGH Study Group.

Cancer. 2018 May 1;124(9):1964-1972. doi: 10.1002/cncr.31215. Epub 2018 Mar 28.

16.

Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib.

Mulé S, Thiefin G, Costentin C, Durot C, Rahmouni A, Luciani A, Hoeffel C.

Radiology. 2018 Aug;288(2):445-455. doi: 10.1148/radiol.2018171320. Epub 2018 Mar 27.

PMID:
29584597
17.

Hepatocellular Carcinoma With Portal Venous Invasion: Radiating New Hope?

Farsad K, Costentin CE, Zhu AX.

JAMA Oncol. 2018 May 1;4(5):669-670. doi: 10.1001/jamaoncol.2018.0007. No abstract available.

PMID:
29543953
18.

Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.

Chalaye J, Costentin CE, Luciani A, Amaddeo G, Ganne-Carrié N, Baranes L, Allaire M, Calderaro J, Azoulay D, Nahon P, Seror O, Mallat A, Soussan M, Duvoux C, Itti E, Nault JC.

J Hepatol. 2018 Aug;69(2):336-344. doi: 10.1016/j.jhep.2018.02.018. Epub 2018 Mar 6.

PMID:
29518452
19.

Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

Ziol M, Poté N, Amaddeo G, Laurent A, Nault JC, Oberti F, Costentin C, Michalak S, Bouattour M, Francoz C, Pageaux GP, Ramos J, Decaens T, Luciani A, Guiu B, Vilgrain V, Aubé C, Derman J, Charpy C, Zucman-Rossi J, Barget N, Seror O, Ganne-Carrié N, Paradis V, Calderaro J.

Hepatology. 2018 Jul;68(1):103-112. doi: 10.1002/hep.29762. Epub 2018 May 9.

PMID:
29281854
20.

Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment Strategy.

Costentin CE, Ferrone CR, Arellano RS, Ganguli S, Hong TS, Zhu AX.

Liver Cancer. 2017 Nov;6(4):360-374. doi: 10.1159/000481315. Epub 2017 Oct 19. Review.

21.

Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?

Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A.

Abdom Radiol (NY). 2018 Aug;43(8):2212. doi: 10.1007/s00261-017-1423-x.

PMID:
29230554
22.

Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?

Roux M, Pigneur F, Baranes L, Calderaro J, Chiaradia M, Decaens T, Kastahian S, Charles-Nelson A, Tselikas L, Costentin C, Laurent A, Azoulay D, Mallat A, Rahmouni A, Luciani A.

Abdom Radiol (NY). 2018 Jul;43(7):1670-1681. doi: 10.1007/s00261-017-1377-z. Erratum in: Abdom Radiol (NY). 2017 Dec 11;:.

PMID:
29110059
23.

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group.

Lancet Oncol. 2017 Dec;18(12):1624-1636. doi: 10.1016/S1470-2045(17)30683-6. Epub 2017 Oct 26.

PMID:
29107679
24.

Multielectron, multisubstrate molecular catalysis of electrochemical reactions: Formal kinetic analysis in the total catalysis regime.

Costentin C, Nocera DG, Brodsky CN.

Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11303-11308. doi: 10.1073/pnas.1711129114. Epub 2017 Oct 9.

25.

Catalysis and Inhibition in the Electrochemical Reduction of CO2 on Platinum in the Presence of Protonated Pyridine. New Insights into Mechanisms and Products.

Dridi H, Comminges C, Morais C, Meledje JC, Kokoh KB, Costentin C, Savéant JM.

J Am Chem Soc. 2017 Oct 4;139(39):13922-13928. doi: 10.1021/jacs.7b08028. Epub 2017 Sep 25.

PMID:
28892610
26.

Self-healing catalysis in water.

Costentin C, Nocera DG.

Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13380-13384. doi: 10.1073/pnas.1711836114. Epub 2017 Sep 5.

27.

Nanodiffusion in electrocatalytic films.

Costentin C, Di Giovanni C, Giraud M, Savéant JM, Tard C.

Nat Mater. 2017 Oct;16(10):1016-1021. doi: 10.1038/nmat4968. Epub 2017 Aug 21.

PMID:
28825730
28.

[Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017].

Costentin C, Ganne-Carrié N, Rousseau B, Gérolami R, Barbare JC.

Bull Cancer. 2017 Sep;104(9):752-761. doi: 10.1016/j.bulcan.2017.06.008. Epub 2017 Jul 24. Review. French.

PMID:
28751065
29.

One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience.

Barrault C, Lison H, Roudot-Thoraval F, Garioud A, Costentin C, Béhar V, Medmoun M, Pulwermacher G, Hagège H, Cadranel JF.

Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1155-1160. doi: 10.1097/MEG.0000000000000922.

PMID:
28727631
30.

Cyclic voltammetry modeling of proton transport effects on redox charge storage in conductive materials: application to a TiO2 mesoporous film.

Kim YS, Balland V, Limoges B, Costentin C.

Phys Chem Chem Phys. 2017 Jul 21;19(27):17944-17951. doi: 10.1039/c7cp02810e. Epub 2017 Jun 30.

PMID:
28664973
31.

Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis.

Costentin CE, Decaens T, Laurent A, Nault JC, Paule B, Letoublon C, Luciani A, Calderaro J, Adam R, Bricault I, Amaddeo G, Cherqui D, Mallat A, Samuel D, Duvoux C, Ganne-Carrié N, Roudot-Thoraval F, Vibert E.

Liver Int. 2017 Dec;37(12):1869-1876. doi: 10.1111/liv.13491. Epub 2017 Jul 13.

PMID:
28609020
32.

Heterogeneous Molecular Catalysis of Electrochemical Reactions: Volcano Plots and Catalytic Tafel Plots.

Costentin C, Savéant JM.

ACS Appl Mater Interfaces. 2017 Jun 14;9(23):19894-19899. doi: 10.1021/acsami.7b04349. Epub 2017 Jun 2.

PMID:
28530798
33.

Simultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC-MS/MS.

Allard M, Khoudour N, Rousseau B, Joly C, Costentin C, Blanchet B, Tournigand C, Hulin A.

J Pharm Biomed Anal. 2017 Aug 5;142:42-48. doi: 10.1016/j.jpba.2017.04.053. Epub 2017 May 1.

PMID:
28494338
34.

Homogeneous Molecular Catalysis of Electrochemical Reactions: Catalyst Benchmarking and Optimization Strategies.

Costentin C, Savéant JM.

J Am Chem Soc. 2017 Jun 21;139(24):8245-8250. doi: 10.1021/jacs.7b02879. Epub 2017 Jun 13.

PMID:
28460524
35.

Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.

Menahem B, Lubrano J, Duvoux C, Mulliri A, Alves A, Costentin C, Mallat A, Launoy G, Laurent A.

Liver Transpl. 2017 Jun;23(6):836-844. doi: 10.1002/lt.24758. Review.

36.

Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.

Costentin CE, Amaddeo G, Decaens T, Boudjema K, Bachellier P, Muscari F, Salamé E, Bernard PH, Francoz C, Dharancy S, Vanlemmens C, Radenne S, Dumortier J, Hilleret MN, Chazouillères O, Pageaux GP, Calderaro J, Laurent A, Roudot-Thoraval F, Duvoux C; Liver Transplantation French Study Group.

Liver Int. 2017 May;37(5):717-726. doi: 10.1111/liv.13388. Epub 2017 Mar 24.

PMID:
28199760
37.

How Do Pseudocapacitors Store Energy? Theoretical Analysis and Experimental Illustration.

Costentin C, Porter TR, Savéant JM.

ACS Appl Mater Interfaces. 2017 Mar 15;9(10):8649-8658. doi: 10.1021/acsami.6b14100. Epub 2017 Mar 1.

PMID:
28195702
38.

Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.

Cadier B, Bulsei J, Nahon P, Seror O, Laurent A, Rosa I, Layese R, Costentin C, Cagnot C, Durand-Zaleski I, Chevreul K; ANRS CO12 CirVir and CHANGH groups.

Hepatology. 2017 Apr;65(4):1237-1248. doi: 10.1002/hep.28961. Epub 2017 Feb 8.

PMID:
28176349
39.

[Hepatocellular carcinoma surveillance].

Costentin C.

Presse Med. 2017 Apr;46(4):381-385. doi: 10.1016/j.lpm.2016.11.006. Epub 2017 Jan 9. French.

PMID:
28081946
40.

Through-Space Charge Interaction Substituent Effects in Molecular Catalysis Leading to the Design of the Most Efficient Catalyst of CO2-to-CO Electrochemical Conversion.

Azcarate I, Costentin C, Robert M, Savéant JM.

J Am Chem Soc. 2016 Dec 28;138(51):16639-16644. doi: 10.1021/jacs.6b07014. Epub 2016 Dec 15.

PMID:
27976580
41.

Catalysis at the nanoscale may change selectivity.

Costentin C, Savéant JM.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11756-11758. Epub 2016 Sep 29.

42.

Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.

Tselikas L, Pigneur F, Roux M, Baranes L, Costentin C, Roche V, Calderaro J, Herin E, Laurent A, Zafrani E, Azoulay D, Mallat A, Rahmouni A, Luciani A.

Abdom Radiol (NY). 2017 Mar;42(3):825-832. doi: 10.1007/s00261-016-0921-6.

PMID:
27704147
43.

Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation.

de'Angelis N, Landi F, Nencioni M, Palen A, Lahat E, Salloum C, Compagnon P, Lim C, Costentin C, Calderaro J, Luciani A, Feray C, Azoulay D.

Prog Transplant. 2016 Dec;26(4):348-355. doi: 10.1177/1526924816664083. Epub 2016 Sep 20.

PMID:
27555074
44.

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features.

Calderaro J, Rousseau B, Amaddeo G, Mercey M, Charpy C, Costentin C, Luciani A, Zafrani ES, Laurent A, Azoulay D, Lafdil F, Pawlotsky JM.

Hepatology. 2016 Dec;64(6):2038-2046. doi: 10.1002/hep.28710. Epub 2016 Aug 9.

PMID:
27359084
45.

Efficient electrolyzer for CO2 splitting in neutral water using earth-abundant materials.

Tatin A, Comminges C, Kokoh B, Costentin C, Robert M, Savéant JM.

Proc Natl Acad Sci U S A. 2016 May 17;113(20):5526-9. doi: 10.1073/pnas.1604628113. Epub 2016 May 2.

46.

Conduction and Reactivity in Heterogeneous-Molecular Catalysis: New Insights in Water Oxidation Catalysis by Phosphate Cobalt Oxide Films.

Costentin C, Porter TR, Savéant JM.

J Am Chem Soc. 2016 May 4;138(17):5615-22. doi: 10.1021/jacs.6b00737. Epub 2016 Apr 25.

PMID:
26981886
47.

Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.

Boussouar S, Itti E, Lin SJ, Decaens T, Evangelista E, Chiaradia M, Chalaye J, Baranes L, Calderaro J, Laurent A, Pigneur F, Duvoux C, Azoulay D, Costentin C, Rahmouni A, Luciani A.

Cancer Imaging. 2016 Feb 16;16:4. doi: 10.1186/s40644-016-0062-8.

48.

Current Issues in Molecular Catalysis Illustrated by Iron Porphyrins as Catalysts of the CO2-to-CO Electrochemical Conversion.

Costentin C, Robert M, Savéant JM.

Acc Chem Res. 2015 Dec 15;48(12):2996-3006. doi: 10.1021/acs.accounts.5b00262. Epub 2015 Nov 12.

PMID:
26559053
49.

Molecular Catalysis of O2 Reduction by Iron Porphyrins in Water: Heterogeneous versus Homogeneous Pathways.

Costentin C, Dridi H, Savéant JM.

J Am Chem Soc. 2015 Oct 28;137(42):13535-44. doi: 10.1021/jacs.5b06834. Epub 2015 Oct 16.

PMID:
26414306
50.

Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors.

Nault JC, Pigneur F, Nelson AC, Costentin C, Tselikas L, Katsahian S, Diao G, Laurent A, Mallat A, Duvoux C, Luciani A, Decaens T.

Dig Liver Dis. 2015 Oct;47(10):869-76. doi: 10.1016/j.dld.2015.07.001. Epub 2015 Jul 10.

PMID:
26211871

Supplemental Content

Loading ...
Support Center